Unavailable Treatments

In January 2019 we received reports of difficulty in obtaining Bettamousse 0.1% Cutaneous Foam (betamethasone valerate). We contacted RPH Pharmaceuticals AB, the manufacturer of Bettamousse, who confirmed that there is currently an availability issue with the product.

RPH Pharmaceuticals AB is changing its manufacturing site and with this comes the lengthy regulations and checking of the product before re-issue. They initially anticipated it would be out of stock until the end of 2018, but Bettamousse is now expected to be out of stock until April 2019.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 0845 023 0467, or by email at customer.care@recipharm.com. 

In October 2018, we were contacted by Pierre Fabre Dermo-Cosmetique, the manufacturer of topical corticosteroid treatment, Clarelux foam, regarding the ongoing unavailability of the product. They confirmed that, due to supply issues with the product, they do not currently know when it will be back on the market again. The latest estimate is 2020.

There are no safety issues with the product so available stock can still be used.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 0208 731 3322, or by email at medicalinformation@pierre-fabre.co.uk.

In summer 2018 we received a number of reports of difficulty obtaining Ceanel Shampoo, which is commonly used to manage scalp psoriasis. In September 2018 we contacted Alliance Pharmaceuticals, the manufacturer of Ceanel Shampoo, who confirmed that the product is currently out of production and they do not yet have a date for when it may be available again.

A representative from the manufacturer stated 'Unfortunately, Ceanel shampoo is currently out of production as we are having difficulty in sourcing some of the raw materials. We do not have a date for when it may be available.

In the meantime, we would recommend that patients discuss suitable alternatives with a healthcare professional (e.g. GP or Pharmacist).

There were no safety concerns for products on the market, however, all stock will now have passed its expiry date.'

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01249 466 966, or by email at medinfo@alliancepharma.co.uk.